Proximal Hamstring Tendinopathy (Investigational)
Investigational adjunct for chronic proximal hamstring tendinopathy at ischial origin; eccentric loading and load management remain primary.
Patienten-Zusammenfassung
- Ist dies FDA-zugelassen fuer diese Anwendung?
- Not FDA-cleared for proximal hamstring tendinopathy. FDA cleared medicinal leeches only for venous congestion in microsurgical reconstruction (K040187, 2004). Use here is investigational.
- Welche Evidenz existiert?
- Tier C (investigational). There are no published controlled trials for proximal hamstring tendinopathy. Evidence-based care: load management, eccentric and heavy slow-resistance training (the strongest tendinopathy evidence), gradual return-to-sport progression, addressing biomechanics (gluteal and core weakness, sitting posture), and (for refractory cases) shock-wave therapy or PRP injection. Corticosteroid injection at the ischial tuberosity is sometimes used but carries a small risk of tendon rupture. Surgical repair is reserved for tendon avulsion or refractory tendinopathy.
- Hauptrisiken
- Bleeding from each bite site for 6 to 24 hours after detachment
- Bruising over the ischial tuberosity area or posterior thigh for 5 to 10 days
- Local skin or, rarely, Aeromonas hydrophila infection
- Allergic reaction to leech saliva (uncommon)
- Risk if placed too close to the sciatic nerve, which runs near the ischial tuberosity
- Worsening tendon pain from local irritation
- Delay of evidence-based eccentric loading and heavy slow-resistance training
- Wer dies nicht in Betracht ziehen sollte
- Patients with suspected hamstring tendon avulsion or near-complete tear (surgical evaluation)
- Patients with sciatic nerve symptoms (radiating pain down the leg, foot drop, numbness)
- Patients with ischial bursitis, lumbar radiculopathy, or sacroiliac dysfunction mimicking the syndrome
- Patients who have not completed at least 12 weeks of structured eccentric loading
- Patients on anticoagulants, with hemophilia, or with severe anemia
- Patients with active dermatitis or broken skin over the posterior thigh
- Was Sie Ihren Kliniker fragen sollten
- Have I had MRI or ultrasound to rule out tendon avulsion or near-complete tear?
- Have I been worked up for ischial bursitis, lumbar radiculopathy, or sacroiliac dysfunction as alternatives?
- Have I completed a structured 12-week eccentric and heavy slow-resistance training program?
- Have I addressed gluteal and core strength, sitting posture, and sport-specific biomechanics?
- Have I tried shock-wave therapy or PRP, and what is their evidence vs. this investigational option?
- Where exactly will leeches be placed - confirm placement is well clear of the sciatic nerve and ischial tuberosity?
- What is the practitioner's plan if symptoms do not improve after 2 to 3 sessions?
- Wann dringende medizinische Versorgung suchen
- Sudden severe pop or pain with inability to walk (possible tendon avulsion)
- Sudden radiating pain down the leg, foot drop, or loss of sensation (possible sciatic nerve injury)
- Acute severe swelling, bruising, or hematoma in the posterior thigh
- Bleeding from a bite site lasting more than 24 hours
- Fever, chills, or spreading redness at the bite site
- Hives, facial or throat swelling, or breathing difficulty
Was dies NICHT bedeutet
- This is not FDA-cleared for proximal hamstring tendinopathy.
- No controlled trials support efficacy; placebo response is high in chronic tendinopathy.
- It does not replace eccentric loading and heavy slow-resistance training, which have the strongest tendinopathy evidence.
- It does not address tendon avulsion or near-complete tear, which need surgical evaluation.
- Placement near the ischial tuberosity carries sciatic nerve injury risk if practitioner is not skilled.
Sicherheits-Querverweise
Clinical Profile
- Category
- musculoskeletal
- ICD-10
- M76.81, M76.82
- Safety tier
- high
Evidence Summary
Proximal hamstring tendinopathy presents as deep gluteal pain at the ischial tuberosity, worsened by sitting and acceleration. Evidence-based management includes load management, progressive eccentric hamstring loading, hip-stability exercise, and selective shock-wave therapy or PRP. Surgery is reserved for confirmed tears. No controlled clinical trial of peri-tendinous hirudotherapy for proximal hamstring tendinopathy has been published; any use is investigational and mechanistic only. The sciatic nerve runs immediately lateral to the ischial tuberosity, so placement must respect that anatomy.
Treatment specifics
How many leeches, where they are placed, how long a session lasts, and whether to repeat are clinical decisions made by a qualified provider under institutional protocol — not something to self-administer. Discuss the specifics with a clinician experienced in medicinal leech therapy. (Clinicians: switch the audience selector in the top bar to “Clinician” to view protocol detail.)
Key Trials
- Michalsen A (2007)0
Contraindications
- Active anticoagulant therapy (warfarin INR >2.0, DOACs, heparin)
- Hemophilia or other bleeding disorder
- Severe anemia (Hb <10 g/dL)
- Active bacteremia or sepsis
- Known hypersensitivity to leech salivary proteins
- Pregnancy (relative — first/third trimester)
- Immunocompromised state with severe neutropenia
- Avulsion injury or high-grade partial tear (MRI; surgical consultation)
- Sciatic nerve symptoms in lower limb (rule out radiculopathy or deep gluteal syndrome)
- Discontinuation of hamstring loading program
- Direct placement over ischial tuberosity (sciatic nerve proximity)
Related Conditions
Knee Osteoarthritis
Off-label use with three RCTs showing pain and function improvement comparable to NSAID gel at 3 months in mild-to-moderate symptomatic knee OA.
Thumb Carpometacarpal (CMC-1) Osteoarthritis
Off-label use with RCT evidence: single-session leech therapy reduces pain and improves function in CMC-1 (basal thumb) OA at 8 weeks.
Lateral Epicondylitis (Tennis Elbow)
Off-label use with two RCTs showing significant pain reduction at 7-12 weeks compared to topical NSAID and conventional physiotherapy.
Plantar Fasciitis
Off-label use with one RCT showing significant heel pain reduction at 6 weeks compared to conservative care.